Use of Glucose-Lowering Agents in Diabetes and CKD

Diabetes is the most common cause of kidney failure worldwide. Patients with diabetes and chronic kidney disease (CKD) are also at markedly higher risk of cardiovascular disease, particularly heart failure (HF), and death. Through the processes of gluconeogenesis and glucose reabsorption, the kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Alicic, Radica Z., Neumiller, Joshua J., Galindo, Rodolfo J., Tuttle, Katherine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727535/
https://www.ncbi.nlm.nih.gov/pubmed/36506243
http://dx.doi.org/10.1016/j.ekir.2022.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727535/
https://www.ncbi.nlm.nih.gov/pubmed/36506243
http://dx.doi.org/10.1016/j.ekir.2022.09.018

Ejemplares similares